Journal article icon

Journal article

Why, when and how should hypertriglyceridemia be treated in the high-risk cardiovascular patient?

Abstract:

Recent epidemiology attests that hypertriglyceridemia may be a causal risk factor for cardiovascular disease (CVD). The specific atherogenicity of hypertriglyceridemia relates to the accumulation in plasma of triglyceride-rich lipoprotein remnants. Hypertriglyceridemia also drives a 'global' atherogenic dyslipidemic profile, which is frequent in high-risk cardiovascular patients, such as Type 2 diabetics. Elevated triglyceride in fasting or nonfasting blood samples should be a trigger for ass...

Expand abstract

Actions


Access Document


Publisher copy:
10.1586/erc.11.61

Authors


More by this author
Institution:
University of Oxford
Division:
MSD
Department:
RDM
Sub department:
OCDEM
Role:
Author
Journal:
Expert Review of Cardiovascular Therapy More from this journal
Volume:
9
Issue:
8
Pages:
987-997
Publication date:
2011-08-01
DOI:
EISSN:
1744-8344
ISSN:
1477-9072
Language:
English
Keywords:
Pubs id:
pubs:179748
UUID:
uuid:21fe6125-f13e-4528-bb90-5e41f0df832a
Local pid:
pubs:179748
Source identifiers:
179748
Deposit date:
2012-12-19

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP